NordiQC Assessments of CD117 Immunoassays.


Journal

Applied immunohistochemistry & molecular morphology : AIMM
ISSN: 1533-4058
Titre abrégé: Appl Immunohistochem Mol Morphol
Pays: United States
ID NLM: 100888796

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 1 12 2018
medline: 6 5 2020
entrez: 1 12 2018
Statut: ppublish

Résumé

This paper is the number 5 in a series developed through a partnership between ISIMM and NordiQC for the purpose of reporting research assessing the performance characteristics of immunoassays in an external proficiency-testing program.

Identifiants

pubmed: 30499819
doi: 10.1097/PAI.0000000000000714
doi:

Substances chimiques

Proto-Oncogene Proteins c-kit EC 2.7.10.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

87-91

Auteurs

Rasmus Røge (R)

Institute of Pathology, Aalborg University Hospital.
Department of Clinical Medicine, Aalborg University, Aalborg.

Michael Bzorek (M)

Department of Surgical Pathology, Zealand University Hospital, Koegevej, Roskilde.

Ole Nielsen (O)

Department of Pathology, Odense University Hospital, Winslowparken, Odense City, Denmark.

Mogens Vyberg (M)

Institute of Pathology, Aalborg University Hospital.
Department of Clinical Medicine, Aalborg University, Aalborg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH